This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Getting a Charge From Emerson Electric and Its CEO

Stocks in this article: EMR

The Journal article quoted Scott Davis of Barclays Capital as saying about Farr that he "is well-liked and proven, yet his questionable outbursts at analyst events and conference calls do not inspire confidence."

In an interview mentioned in the article, Jeffrey Sprague of Vertical Research Partners aired similar concerns. "I always take such comments from David with a grain of salt, because he is very aggressive, passionate and competitive. I don't think he means any harm, but I do think he at times goes too far, which needlessly raises investor questions and concerns," Sprague said.

To that last part I beg to differ. I'm not approving of public profusions of profanity, but I'm even less tolerant of the media judging an obviously outstanding corporate leader by an occasional outburst or two. Farr's candor and willingness to call a pig's ear a pig's ear and not a silk purse is rather endearing. Plus, if you've ever seen him on Jim Cramer's "Mad Money" TV show you know he's a good communicator.

Also endearing is the notion of owning shares of a company as fiscally sound as EMR. This industry titan with a market cap of over $41 billion has given its shareholders a return on equity (trailing 12 months) of over 20% and a dividend that by the end of 2012 had grown to $1.64 per share.

Now, if the current correction happens to suppress EMR's share price to around $56, it would lift the dividend's yield to price to almost 3%. Quite remarkable for a company whose past 52-week stock price performance outperformed the S&P 500 by nearly 30%!

Jim Cramer and Stephanie Link actively manage a real money portfolio for his charitable trust-- enjoy advance notice of every trade, full access to the portfolio, and deep coverage of the latest economic events and market movements.

Currently the share price is 14% above its 200-day moving average price of slightly more than $50. As the chart below shows us, EMR's diluted quarterly year-over-year EPS growth is the "power" that's driving the share price. Farr's remarks are the least colorful part of this profitable company.

EMR Chart EMR data by YCharts

An Emerson spokesperson was quoted by the Wall Street Journal as saying that "to some degree, these remarks by CEO Farr were lighthearted and are taken out of context." The same added that Farr's "willingness to be candid and open with investors is welcomed and appreciated. He is recognized for his charisma and thought leadership."

2 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs